Work

Afatinib is especially effective against non-small cell lung cancer carrying an EGFR exon 19 deletion.

Year: 2015

Type: article

Source: PubMed

Authors: Eri Banno, Yosuke Togashi, Yoshihisa Kobayashi, Hidetoshi Hayashi, Tetsuya Mitsudomi, Kazuto Nishio

Institutions: Kindai University, Kishiwada City Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2110113106

FWCI: 2.121

Cites: 15

Cited by: 17

Related to: 10